Metraipolis › archive › dc_c44207c25d5a

CircZBTB46 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miRNA-326/FGF1 axis — Europe PMC PMID:41513602

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41513602
DOI
10.1038/s41420-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-06T22:48:48.699Z
SHA-256 of the archived text
fce2fb173abeb84d5e5190a0a993cde66b9213b2422ea9a5e6152162efca2dd0
Stable URL of this page
https://metraipolis.com/documento/dc_c44207c25d5a

How to cite

CircZBTB46 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miRNA-326/FGF1 axis — Europe PMC PMID:41513602 — Europe PMC (en), https://europepmc.org/article/MED/41513602 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c44207c25d5a (Metraipolis archive dc_c44207c25d5a, sha256 fce2fb173abeb84d5e5190a0a993cde66b9213b2422ea9a5e6152162efca2dd0)
BibTeX
@misc{dcc44207c25d5a,
  title = {CircZBTB46 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miRNA-326/FGF1 axis — Europe PMC PMID:41513602},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41513602},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c44207c25d5a; sha256 fce2fb173abeb84d5e5190a0a993cde66b9213b2422ea9a5e6152162efca2dd0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41513602. Agents can read the archived copy with the MCP tool read_document.